Total Payments
$2,933
2024 Payments
$1,269
Companies
23
Transactions
156
Medicare Patients
6,568
Medicare Billing
$828,290
Payment Breakdown by Category
Food & Beverage$2,604 (88.8%)
Education$328.33 (11.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,604 | 152 | 88.8% |
| Education | $328.33 | 4 | 11.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $650.12 | 20 | $0 (2024) |
| Dermavant Sciences, Inc. | $340.40 | 14 | $0 (2024) |
| Lilly USA, LLC | $298.70 | 11 | $0 (2024) |
| Promius Pharma LLC | $227.58 | 53 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $199.57 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $166.27 | 10 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $163.44 | 9 | $0 (2024) |
| Galderma Laboratories, L.P. | $139.34 | 3 | $0 (2024) |
| ABBVIE INC. | $120.85 | 5 | $0 (2024) |
| GENZYME CORPORATION | $110.79 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,269 | 43 | Janssen Biotech, Inc. ($273.07) |
| 2023 | $812.25 | 33 | Janssen Biotech, Inc. ($246.29) |
| 2022 | $248.34 | 10 | Janssen Biotech, Inc. ($82.14) |
| 2021 | $107.80 | 5 | Janssen Biotech, Inc. ($28.90) |
| 2020 | $33.25 | 2 | Regeneron Healthcare Solutions, Inc. ($21.18) |
| 2019 | $101.18 | 6 | Janssen Scientific Affairs, LLC ($31.81) |
| 2018 | $196.18 | 25 | Promius Pharma LLC ($111.60) |
| 2017 | $164.87 | 32 | Promius Pharma LLC ($115.98) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.41 | General |
| Category: Immunology | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $45.38 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $94.99 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $30.86 | General |
| Category: Inflammation | ||||||
| 11/22/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: DERMATOLOGY | ||||||
| 11/18/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $29.95 | General |
| Category: Immunology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $28.63 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $16.25 | General |
| Category: Dermatology | ||||||
| 11/01/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.48 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.57 | General |
| 10/28/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Immunology | ||||||
| 09/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.22 | General |
| Category: Immunology | ||||||
| 09/05/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $21.53 | General |
| 08/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.46 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/30/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: Immunology | ||||||
| 07/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: Immunology | ||||||
| 07/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: DERMATOLOGY | ||||||
| 07/02/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.61 | General |
| Category: Immunology | ||||||
| 06/18/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,593 | 2,850 | $1.4M | $203,378 |
| 2022 | 13 | 1,565 | 2,852 | $1.3M | $207,945 |
| 2021 | 15 | 1,620 | 3,184 | $1.1M | $219,434 |
| 2020 | 16 | 1,790 | 3,335 | $1.0M | $197,532 |
Total Patients
6,568
Total Services
12,221
Medicare Billing
$828,290
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 464 | 904 | $587,600 | $98,096 | 16.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 255 | 433 | $222,080 | $32,739 | 14.7% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2023 | 66 | 294 | $113,190 | $17,979 | 15.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 221 | 315 | $146,965 | $16,631 | 11.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 115 | 128 | $81,920 | $10,861 | 13.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 67 | 67 | $51,015 | $6,016 | 11.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 52 | 56 | $34,440 | $5,242 | 15.2% |
| 11312 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 29 | 30 | $27,060 | $4,357 | 16.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 30 | $28,760 | $4,160 | 14.5% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 18 | 18 | $14,190 | $2,324 | 16.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 11 | $16,870 | $1,828 | 10.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 162 | 226 | $19,192 | $1,353 | 7.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 16 | $6,900 | $806.84 | 11.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 14 | 15 | $5,475 | $735.75 | 13.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 75 | 307 | $3,100 | $250.47 | 8.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 465 | 878 | $570,700 | $98,592 | 17.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 249 | 451 | $202,950 | $36,155 | 17.8% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2022 | 67 | 302 | $116,270 | $19,911 | 17.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 241 | 346 | $147,050 | $18,874 | 12.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 132 | 157 | $100,480 | $14,223 | 14.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 39 | 40 | $33,800 | $6,632 | 19.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 36 | 38 | $23,370 | $4,329 | 18.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 39 | 39 | $26,130 | $3,443 | 13.2% |
| 11312 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2022 | 11 | 12 | $8,565 | $1,753 | 20.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 178 | 248 | $17,496 | $1,588 | 9.1% |
About Dr. Tobi Klar, MD
Dr. Tobi Klar, MD is a Dermatology healthcare provider based in Larchmont, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609934264.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tobi Klar, MD has received a total of $2,933 in payments from pharmaceutical and medical device companies, with $1,269 received in 2024. These payments were reported across 156 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,604).
As a Medicare-enrolled provider, Klar has provided services to 6,568 Medicare beneficiaries, totaling 12,221 services with total Medicare billing of $828,290. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Larchmont, NY
- Active Since 12/05/2006
- Last Updated 03/06/2018
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1609934264
Products in Payments
- TREMFYA (Drug) $583.97
- DUPIXENT (Biological) $310.36
- VTAMA (Drug) $193.73
- TALTZ (Drug) $163.82
- Sotyktu (Drug) $163.44
- Otezla (Drug) $133.37
- Trianex (Drug) $118.93
- EBGLYSS (Drug) $112.78
- EPSOLAY (Drug) $103.24
- RINVOQ (Biological) $94.23
- EUCRISA (Drug) $93.55
- COSENTYX (Biological) $57.74
- COSENTYX (Drug) $57.12
- Bimzelx (Biological) $52.55
- Cloderm Cream (Drug) $50.86
- IMBRUVICA (Drug) $48.62
- OPZELURA (Drug) $45.33
- VALCHLOR MECHLORETHAMINE (Drug) $35.83
- Sernivo Spray (Drug) $35.51
- XOLAIR (Biological) $34.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.